$61.70 -2.71 (%) Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Apr. 27, 2015 | 02:50 PM

Partner Headlines

  1. 4 Drug Giants Reporting Earnings This Week

    IBD | Apr. 27, 2015 | 13:33PM EST
  2. Mylan Rejects Teva Bid After Raising Bid For Perrigo

    IBD | Apr. 27, 2015 | 12:45PM EST
  3. Teva Puts Forth Its Best Bid To Acquire Mylan

    GuruFocus | Apr. 25, 2015 | 19:34PM EST
  4. Perrigo rebuffs Mylan again

    IBD | Apr. 24, 2015 | 19:12PM EST
  5. Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds

    IBD | Apr. 24, 2015 | 17:51PM EST
  6. Benzinga's M&A Chatter for Wednesday April 22, 2015

    Benzinga | Apr. 22, 2015 | 17:47PM EST
  7. Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan

    Benzinga | Apr. 22, 2015 | 08:33AM EST
  8. Teva Offers $40 Bil For Mylan; Perrigo Rejects Mylan

    IBD | Apr. 21, 2015 | 19:04PM EST
  9. Teva Offers, Perrigo Rejects

    IBD | Apr. 21, 2015 | 18:51PM EST
  10. Stocks End Mixed As Technology Sector Leads

    IBD | Apr. 21, 2015 | 16:34PM EST
  11. Buyers Prop Up Nasdaq; Chipotle Rises Ahead Of Earnings

    IBD | Apr. 21, 2015 | 14:49PM EST
  12. Stocks Mixed, But Palo Alto Hits High On Analyst Nod

    IBD | Apr. 21, 2015 | 12:07PM EST
  13. Teva Bids $40 Billion For Mylan, But May Need More

    IBD | Apr. 21, 2015 | 11:35AM EST
  14. Benzinga's Volume Movers

    Benzinga | Apr. 21, 2015 | 11:29AM EST
  15. Mylan Shares Jump On $40 Billion Bid From Teva Pharmaceutical

    Benzinga | Apr. 21, 2015 | 10:52AM EST
  16. Stocks Slip Into Mixed Trade; DuPont, Harley-Davidson Dive

    IBD | Apr. 21, 2015 | 10:35AM EST
  17. Teva Offers $82 A Share For Mylan; Stocks Rise

    IBD | Apr. 21, 2015 | 09:17AM EST
  18. Stock Futures Mildly Positive; Mylan, Fortinet, Mellanox Surge

    IBD | Apr. 21, 2015 | 09:01AM EST
  19. Teva Pharmaceutical

    IBD | Apr. 20, 2015 | 18:43PM EST
  20. Benzinga's Weekend M&A Chatter

    Benzinga | Apr. 19, 2015 | 19:10PM EST
  21. Mylan

    IBD | Apr. 17, 2015 | 18:51PM EST
  22. Global Worries Sink U.S. Stocks; Apple Breaches Support Level

    IBD | Apr. 17, 2015 | 16:37PM EST
  23. Teva Getting Serious About Mylan Bid, Says Report

    IBD | Apr. 17, 2015 | 15:54PM EST
  24. 8 IBD 50 Stocks Bucking The Market Sell-Off

    IBD | Apr. 17, 2015 | 15:36PM EST
  25. Mylan: There's No Logic In The Teva Merger Rumor

    Benzinga | Apr. 17, 2015 | 15:17PM EST
  26. Stocks Bleed Some More; Nasdaq Breaches Support Level

    IBD | Apr. 17, 2015 | 14:57PM EST
  27. Mylan Scores Final Win In Patent Challenge On Inhalation Drug

    Benzinga | Apr. 17, 2015 | 14:27PM EST
  28. Momenta, Novartis get FDA OK

    IBD | Apr. 16, 2015 | 18:43PM EST
  29. Momenta, Novartis Win FDA Nod For Generic Copaxone

    IBD | Apr. 16, 2015 | 14:39PM EST
  30. Insys Therapeutics Q4 beats

    IBD | Mar. 3, 2015 | 18:32PM EST
  31. Insys Therapeutics Q4 Beat Drives Short-Lived Rally

    IBD | Mar. 3, 2015 | 11:46AM EST
  32. Teva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary and Secondary Endpoints

    Benzinga | Feb. 24, 2015 | 09:04AM EST
  33. Stocks Hitting 52-Week Highs

    Benzinga | Feb. 17, 2015 | 10:09AM EST
  34. Morning Market Gainers

    Benzinga | Feb. 17, 2015 | 09:43AM EST
  35. Three Reasons To Let Akorn Fall Into Your Portfolio

    IBD | Feb. 6, 2015 | 11:11AM EST
  36. Generic-Drug Makers Soar, And It's Easy To See Why

    IBD | Feb. 5, 2015 | 17:33PM EST
  37. Stocks Rise In Weak Trade; LinkedIn Jumps After Hours

    IBD | Feb. 5, 2015 | 17:03PM EST
  38. Stocks Close Near Session Highs, But Volume Softens

    IBD | Feb. 5, 2015 | 16:18PM EST
  39. Opko Health And Teva Pharmaceutical Industries Surge Following Chairman's Resignation

    Benzinga | Feb. 5, 2015 | 11:54AM EST
  40. Analysts are Bullish on IntelliPharmaceuticals Following Deal with Teva Pharmaceuticals

    GuruFocus | Feb. 4, 2015 | 14:39PM EST
  41. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD | Jan. 28, 2015 | 15:35PM EST
  42. Deutsche Bank Offers Quick Thoughts On Teva Pharmaceutical's Generic Nexium

    Benzinga | Jan. 27, 2015 | 09:33AM EST
  43. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
  44. Teva Pharmaceutical

    IBD | Jan. 20, 2015 | 18:45PM EST
  45. Sterne Agee Analyst: Court Win To Boost Net At Teva Pharmaceutical

    Benzinga | Jan. 20, 2015 | 15:50PM EST
  46. Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks

    Benzinga | Jan. 20, 2015 | 13:00PM EST
  47. US Stock Futures Slip Ahead Of Home Price, Consumer Confidence Data

    Benzinga | Dec. 30, 2014 | 07:10AM EST
  48. OncoGenex to Regain Rights to Custirsen from Teva

    Benzinga | Dec. 30, 2014 | 07:03AM EST
  49. United Therapeutics: Will It Pass Peers In 2015?

    IBD | Dec. 12, 2014 | 18:11PM EST
  50. Teva Upgraded On Strength Of Copaxone MS Drug

    IBD | Dec. 12, 2014 | 10:38AM EST
Trading Center